NANOTROL
Dead / Abandoned — Abandoned — failure to respond (as of 18 Feb 2026)
What this means for you
This application is over — abandoned 05 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 99232403
- Mark type
- Stylized text
- Filed
- 13 Jun 2025
- Abandoned
- 05 Feb 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of Oral, IV, Opthalmic, Topical formulation of nanosalsalate Rheumatoid arthritis Osteoarthritis Gout vasculitis Fibromyalgia Inflammatory bowel disease (IBD) Chronic fatigue syndrome Traumatic brain injury (TBI) Chronic traumatic encephalopathy (CTE) Progressive supranuclear palsy (PSP) Non-Alzheimer’s tauopathies Alzheimer's disease Cytokine Storm & Immune Overactivation Cytokine release syndrome (CRS) Graft-versus-host disease (GvHD) Acute respiratory dis
- Class 042 — Scientific and technological services: Scientific study and research in the field(s) of Development services in the field of novel nano-based drug delivery systems
Owner
- Izhar Hasan, princeton, NJ, US
Prosecution history
- 18 Feb 2026 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Feb 2026 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 04 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Nov 2025 — NON-FINAL ACTION E-MAILED
- 04 Nov 2025 — NON-FINAL ACTION WRITTEN
- 03 Nov 2025 — ASSIGNED TO EXAMINER
- 14 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 13 Jun 2025 — NEW APPLICATION ENTERED